S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
Important info on NVDA trade (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
10-year yield is below 4.5%...these dividend growth yields aren’t
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
AI revolution: 3 stocks set to soar as technology evolves
Is there money hiding under these 2 mattress stocks?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
BellRing Brands gets pumped on the Ozempic weight-loss trend
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
Important info on NVDA trade (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
10-year yield is below 4.5%...these dividend growth yields aren’t
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
AI revolution: 3 stocks set to soar as technology evolves
Is there money hiding under these 2 mattress stocks?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
BellRing Brands gets pumped on the Ozempic weight-loss trend
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
Important info on NVDA trade (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
10-year yield is below 4.5%...these dividend growth yields aren’t
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
AI revolution: 3 stocks set to soar as technology evolves
Is there money hiding under these 2 mattress stocks?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
BellRing Brands gets pumped on the Ozempic weight-loss trend
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
Important info on NVDA trade (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
10-year yield is below 4.5%...these dividend growth yields aren’t
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
AI revolution: 3 stocks set to soar as technology evolves
Is there money hiding under these 2 mattress stocks?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
BellRing Brands gets pumped on the Ozempic weight-loss trend

Zentek Stock Price, News & Analysis (NASDAQ:ZTEK)

$1.09
-0.01 (-0.91%)
(As of 11/27/2023 ET)
Compare
Today's Range
$1.06
$1.12
50-Day Range
$1.09
$1.35
52-Week Range
$1.06
$1.96
Volume
14,480 shs
Average Volume
16,709 shs
Market Capitalization
$109.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ZTEK stock logo

About Zentek Stock (NASDAQ:ZTEK)

Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops graphene oxide synthesis and graphene synthesis. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.

ZTEK Stock Price History

ZTEK Stock News Headlines

Zentek Announces Update on the Albany Graphite Project
Important info on NVDA trade
Today, I’m pulling back the curtain on my all-new Everyday Income project. A way for everyday folks to target a couple hundred bucks or more every single day the markets are open… Without breaking a sweat!
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
ZTEK - Zentek Ltd.
Zentek Ltd.: Zentek Announces Normal Course Issuer Bid
Zentek Announces Normal Course Issuer Bid
Zentek Ltd.: Zentek Provides Review of Albany Graphite
Zentek Provides Review of Albany Graphite
See More Headlines
Receive ZTEK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zentek and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/13/2023
Today
11/27/2023
Next Earnings (Estimated)
2/09/2024
Fiscal Year End
3/31/2024

Industry, Sector and Symbol

Industry
Miscellaneous chemical products
Sub-Industry
N/A
Current Symbol
NASDAQ:ZTEK
Employees
29
Year Founded
N/A

Profitability

Net Income
$-10,900,000.00
Pretax Margin
-46,170.01%

Debt

Sales & Book Value

Annual Sales
$50,000.00
Book Value
$0.23 per share

Miscellaneous

Free Float
N/A
Market Cap
$109.96 million
Optionable
Not Optionable
Beta
0.83
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Francis Dube B.Sc.
    COO & Executive Chairman of the Board
  • Mr. Gregory Fenton C.F.A.
    CEO & Director
  • Ms. Wendy Ford CA
    CPA, Chief Financial Officer
  • Dr. Colin van der Kuur B.Sc.
    DMIN, Chief Science Officer
  • Mr. Ryan Shacklock
    Senior Vice President of Strategy & Business Development














ZTEK Stock Analysis - Frequently Asked Questions

How have ZTEK shares performed in 2023?

Zentek's stock was trading at $1.5499 at the beginning of 2023. Since then, ZTEK stock has decreased by 29.7% and is now trading at $1.09.
View the best growth stocks for 2023 here
.

When is Zentek's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, February 9th 2024.
View our ZTEK earnings forecast
.

How were Zentek's earnings last quarter?

Zentek Ltd. (NASDAQ:ZTEK) issued its earnings results on Monday, November, 13th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm earned $0.01 million during the quarter.

Who are Zentek's major shareholders?

Zentek's stock is owned by many different institutional and retail investors. Top institutional shareholders include Scotia Capital Inc. (0.45%).

How do I buy shares of Zentek?

Shares of ZTEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:ZTEK) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -